72 related articles for article (PubMed ID: 36823199)
1. Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies.
Li J; Wang W; Jiang K; Cui J; Wang C; Liang T; Wang Y; Liu S; Zhou W
J Gastrointest Cancer; 2024 May; ():. PubMed ID: 38713434
[TBL] [Abstract][Full Text] [Related]
2. Prediction Model for Severe Thrombocytopenia Induced by Gemcitabine Plus Cisplatin Combination Therapy in Patients with Urothelial Cancer.
Matsumoto N; Mizuno T; Ando Y; Kato K; Nakanishi M; Nakai T; Lee JK; Kameya Y; Nakamura W; Takahara K; Shiroki R; Yamada S
Clin Drug Investig; 2024 May; 44(5):357-366. PubMed ID: 38684605
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K
BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024
[TBL] [Abstract][Full Text] [Related]
4. Management of Thrombocytopenia in Cancer Patients.
Mones JV; Soff G
Cancer Treat Res; 2019; 179():139-150. PubMed ID: 31317485
[TBL] [Abstract][Full Text] [Related]
5. The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China.
Zhou S; Song B; Li C; Tang W; Zhang X; Jin X; Xu X; Wang Q; Zheng H; Fu J
Sci Rep; 2023 Feb; 13(1):3185. PubMed ID: 36823199
[TBL] [Abstract][Full Text] [Related]
6. A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors.
Song B; Zhou S; Li C; Zheng H; Zhang X; Jin X; Fu J; Hu H
Int J Gen Med; 2022; 15():8003-8015. PubMed ID: 36345528
[TBL] [Abstract][Full Text] [Related]
7. Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice.
Weycker D; Hatfield M; Grossman A; Hanau A; Lonshteyn A; Sharma A; Chandler D
BMC Cancer; 2019 Feb; 19(1):151. PubMed ID: 30764783
[TBL] [Abstract][Full Text] [Related]
8. Predicting chemotherapy-induced thrombocytopenia in cancer patients with solid tumors or lymphoma.
Razzaghdoust A; Mofid B; Zangeneh M
J Oncol Pharm Pract; 2020 Apr; 26(3):587-594. PubMed ID: 31315547
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention.
Degliuomini MD; Armstrong K; Mauguen A; Slotkin EK; Roberts SS; Dunkel IJ; Clouser M; Ortiz MV; Soff GA
Pediatr Blood Cancer; 2022 Oct; 69(10):e29776. PubMed ID: 35593014
[TBL] [Abstract][Full Text] [Related]
10. Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists.
Al-Samkari H
Blood Rev; 2024 Jan; 63():101139. PubMed ID: 37914568
[TBL] [Abstract][Full Text] [Related]
11. The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies.
Shaw JL; Nielson CM; Park JK; Marongiu A; Soff GA
Eur J Haematol; 2021 May; 106(5):662-672. PubMed ID: 33544940
[TBL] [Abstract][Full Text] [Related]
12. Cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
